Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection. | Virol Sin | 2022 | 35568375 | PubTator, text mining | PubMed |
| Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery. | Molecules | 2022 | 35566302 | PubTator, text mining | PubMed |
| Phosphoproteomics Unravel HBV Triggered Rewiring of Host Phosphosignaling Events. | Int J Mol Sci | 2022 | 35563518 | PubTator, text mining | PubMed |
| Comparing the Liver Safety Profiles of 4 Next-Generation CGRP Receptor Antagonists to the Hepatotoxic CGRP Inhibitor Telcagepant Using Quantitative Systems Toxicology Modeling. | Toxicol Sci | 2022 | 35556143 | PubTator, text mining | PubMed |
| Structural basis of sodium-dependent bile salt uptake into the liver. | Nature | 2022 | 35545671 | Swiss-Prot, curated | PubMed |
| Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases. | Acta Pharm Sin B | 2022 | 35530145 | PubTator, text mining | PubMed |
| Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study. | Aliment Pharmacol Ther | 2022 | 35514008 | PubTator, text mining | PubMed |
| Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream. | PLoS Pathog | 2022 | 35511797 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis. | Clin Pharmacol Ther | 2022 | 35510337 | PubTator, text mining | PubMed |
| Signature of chronic hepatitis B virus infection in nails and hair. | BMC Infect Dis | 2022 | 35509029 | PubTator, text mining | PubMed |
| PF-07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID-19 patients. | Clin Transl Sci | 2022 | 35505633 | PubTator, text mining | PubMed |
| Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment. | Front Mol Biosci | 2022 | 35495620 | PubTator, text mining | PubMed |
| Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury. | Front Immunol | 2022 | 35493499 | PubTator, text mining | PubMed |
| New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. | Clin Pharmacol Ther | 2022 | 35488474 | PubTator, text mining | PubMed |
| West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19. | Daru | 2022 | 35476297 | PubTator, text mining | PubMed |
| Bile acid linked β-glucan nanoparticles for liver specific oral delivery of biologics. | Biomater Sci | 2022 | 35471198 | PubTator, text mining | PubMed |
| New and effective method to develop primary hepatocytes from liver cancer patients. | Exp Biol Med (Maywood) | 2022 | 35470702 | PubTator, text mining | PubMed |
| PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA. | Cell Death Dis | 2022 | 35468873 | PubTator, text mining | PubMed |
| Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma. | Front Microbiol | 2022 | 35464922 | PubTator, text mining | PubMed |
| Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses. | Viruses | 2022 | 35458494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=42